Tanaleon, Jenelyn .
HRN: 24-15-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/14/2024
12/16/2024
IVT
900
Q6
S/p Primary LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes